Demographic and clinical characteristics, and microbiology results of patients with community-acquired pneumonia
| Patient characteristics | Controls unilateral BALF, n=24 | ICU cohort unilateral BALF, n=8 | ED cohort bilateral BALF, n=7 |
|---|---|---|---|
| Age, years (mean±SE) | 65.1±2.0 | 63.9±3.7 | 52.4±6.3 |
| Male sex (%) | 17 (71) | 2 (25) | 3 (43) |
| APACHE-II score (mean±SE) | Not determined | 27.7±1.5 | 15.3±4.7 |
| 28-day mortality (%) | 1 (4) | 2 (25) | 0 (0) |
| Microbiology | |||
| Streptococcus pneumonia | 3 | 4 | |
| Mycoplasma pneumoniae | – | 1 | |
| Haemophilus influenza | – | 1 | |
| Acinetobacter baumannii | 1 | – | |
| Legionella pneumophila | 1 | – | |
| Pneumocystis jeroveci | 1 | – | |
| No micro-organism identified | 2 | 1 | |
From control patients, BALF was obtained from the right middle lobe. From ICU patients BALF was obtained from the site of infection as visualised on the chest X-ray. From ED patients, BALF was obtained from both the infected site and the contralateral lung.
BALF, bronchoalveolar lavage fluid; ED, emergency department; ICU, intensive care unit.